Palvella Therapeutics, Inc. (PVLA)

Price & Market Data

Price: $126.0

Daily Change: +$3.91 / 3.10%

Daily Range: $120.9 - $126.1

Market Cap: $1,804,186,368

Daily Volume: 155,329

Performance Metrics

1 Week: -2.84%

1 Month: -2.49%

3 Months: 55.28%

6 Months: 61.62%

1 Year: 506.2%

YTD: 20.18%

About Palvella Therapeutics, Inc. (PVLA)

Explore comprehensive market data for Palvella Therapeutics, Inc. (PVLA). Currently priced at 126.0, observe its daily movement of +$3.91 / 3.10%. The total market value is 1,804,186,368. Review its performance across various timeframes, including the last week, month, and year, to understand its trajectory.

Company Details

Employees: 29

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of angiokeratomas and other mTOR-driven skin diseases; and QTORIN pitavastatin for the treatment of disseminated superficial actinic porokeratosis. The company is based in Wayne, Pennsylvania.

Selected stocks

ChoiceOne Financial Services, Inc. (COFS)

Domo, Inc. (DOMO)

Walt Disney Company (The) (DIS)

Whitehawk Therapeutics, Inc. (WHWK)

Hewlett Packard Enterprise Company (HPE)